• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒2(SARS-CoV-2)的眼部传播潜力:综述

Potential of Ocular Transmission of SARS-CoV-2: A Review.

作者信息

Barnett Brad P, Wahlin Karl, Krawczyk Michal, Spencer Doran, Welsbie Derek, Afshari Natalie, Chao Daniel

机构信息

NVISION Eye Centers-South Sacramento, 7501 Hospital Dr. Suite 105, Sacramento, CA 95823, USA.

Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, CA 92093, USA.

出版信息

Vision (Basel). 2020 Sep 1;4(3):40. doi: 10.3390/vision4030040.

DOI:10.3390/vision4030040
PMID:32883010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7559808/
Abstract

PURPOSE OF REVIEW

to provide a prospective on the current mechanisms by which SARS-CoV-2 enters cells and replicates, and its implications for ocular transmission. The literature was analyzed to understand ocular transmission as well as molecular mechanisms by which SARS-CoV-2 enters cells and replicates. Analysis of gene expression profiles from available datasets, published immunohistochemistry, as well as current literature was reviewed, to assess the likelihood that ocular inoculation of SARS-CoV-2 results in systemic infection.

RECENT FINDINGS

The ocular surface and retina have the necessary proteins, Transmembrane Serine Protease 2 (TMPRSS2), CD147, Angiotensin-Converting Enzyme 2 (ACE2) and Cathepsin L (CTSL) necessary to be infected with SARS-CoV-2. In addition to direct ocular infection, virus carried by tears through the nasolacrimal duct to nasal epithelium represent a means of ocular inoculation.

SUMMARY

There is evidence that SARS-CoV-2 may either directly infect cells on the ocular surface, or virus can be carried by tears through the nasolacrimal duct to infect the nasal or gastrointestinal epithelium.

摘要

综述目的

探讨严重急性呼吸综合征冠状病毒2(SARS-CoV-2)进入细胞并复制的当前机制及其对眼部传播的影响。分析文献以了解眼部传播以及SARS-CoV-2进入细胞并复制的分子机制。回顾了现有数据集的基因表达谱分析、已发表的免疫组织化学以及当前文献,以评估SARS-CoV-2眼部接种导致全身感染的可能性。

最新发现

眼表和视网膜具有感染SARS-CoV-2所需的必要蛋白质,即跨膜丝氨酸蛋白酶2(TMPRSS2)、CD147、血管紧张素转换酶2(ACE2)和组织蛋白酶L(CTSL)。除了直接眼部感染外,泪液携带的病毒通过鼻泪管到达鼻上皮是眼部接种的一种方式。

总结

有证据表明,SARS-CoV-2可能直接感染眼表细胞,或者病毒可通过泪液经鼻泪管感染鼻或胃肠道上皮。

相似文献

1
Potential of Ocular Transmission of SARS-CoV-2: A Review.新型冠状病毒2(SARS-CoV-2)的眼部传播潜力:综述
Vision (Basel). 2020 Sep 1;4(3):40. doi: 10.3390/vision4030040.
2
An Eye on COVID-19: A Meta-analysis of Positive Conjunctival Reverse Transcriptase-Polymerase Chain Reaction and SARS-CoV-2 Conjunctivitis Prevalence.关注 COVID-19:对阳性结膜逆转录酶-聚合酶链反应和 SARS-CoV-2 结膜炎患病率的荟萃分析。
Optom Vis Sci. 2021 May 1;98(5):429-436. doi: 10.1097/OPX.0000000000001687.
3
Nasopharyngeal Expression of Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 in Children within SARS-CoV-2-Infected Family Clusters.儿童 SARS-CoV-2 感染家庭聚集中鼻咽部血管紧张素转换酶 2 和跨膜丝氨酸蛋白酶 2 的表达。
Microbiol Spectr. 2021 Dec 22;9(3):e0078321. doi: 10.1128/Spectrum.00783-21. Epub 2021 Nov 3.
4
Evidence of SARS-CoV-2 Transmission Through the Ocular Route.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)经眼部途径传播的证据。
Clin Ophthalmol. 2021 Feb 18;15:687-696. doi: 10.2147/OPTH.S295283. eCollection 2021.
5
ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection.ACE2 和 TMPRSS2 在上皮细胞表面表达,提示其对 SARS-CoV-2 感染的易感性。
Ocul Surf. 2020 Oct;18(4):537-544. doi: 10.1016/j.jtos.2020.06.007. Epub 2020 Jun 13.
6
Effects of vitamin C and D on the mRNA expression of angiotensin converting enzyme 2 receptor, cathepsin L, and transmembrane serine protease in the mouse lungs.维生素 C 和 D 对小鼠肺组织中血管紧张素转换酶 2 受体、组织蛋白酶 L 和跨膜丝氨酸蛋白酶 mRNA 表达的影响。
Libyan J Med. 2022 Dec;17(1):2054111. doi: 10.1080/19932820.2022.2054111.
7
COVID-19 and the Eye: Ocular Manifestations, Treatment and Protection Measures.新型冠状病毒肺炎与眼睛:眼部表现、治疗和防护措施。
Ocul Immunol Inflamm. 2021 Aug 18;29(6):1225-1233. doi: 10.1080/09273948.2021.1977829. Epub 2021 Oct 14.
8
Immunohistochemical Study of SARS-CoV-2 Viral Entry Factors in the Cornea and Ocular Surface.新型冠状病毒在角膜和眼表面的病毒进入因子的免疫组织化学研究。
Cornea. 2020 Dec;39(12):1556-1562. doi: 10.1097/ICO.0000000000002509.
9
Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea.SARS-CoV-2 受体 ACE2 和 TMPRSS2 在人原发性结膜和翼状胬肉细胞系以及小鼠角膜中的表达。
Eye (Lond). 2020 Jul;34(7):1212-1219. doi: 10.1038/s41433-020-0939-4. Epub 2020 May 7.
10
Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.单细胞分析 SARS-CoV-2 受体 ACE2 和刺突蛋白在人心脏中对蛋白酶的预激活表达。
Cardiovasc Res. 2020 Aug 1;116(10):1733-1741. doi: 10.1093/cvr/cvaa191.

引用本文的文献

1
Impact of COVID-19 on Ocular Surface Health: Infection Mechanisms, Immune Modulation, and Inflammatory Responses.2019冠状病毒病对眼表健康的影响:感染机制、免疫调节及炎症反应
Viruses. 2025 Jan 6;17(1):68. doi: 10.3390/v17010068.
2
Monoclonal neutralizing antibodies against SARS-COV-2 S protein.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的单克隆中和抗体
Am J Transl Res. 2024 Feb 15;16(2):681-689. doi: 10.62347/ALXM8429. eCollection 2024.
3
Dyschromatopsia and contrast sensitivity changes in COVID-19 patients.新冠病毒感染患者的色觉异常和对比敏感度变化

本文引用的文献

1
Enhanced contact investigations for nine early travel-related cases of SARS-CoV-2 in the United States.美国九例早期旅行相关 SARS-CoV-2 病例的强化接触者调查。
PLoS One. 2020 Sep 2;15(9):e0238342. doi: 10.1371/journal.pone.0238342. eCollection 2020.
2
SARS-CoV-2 Infection Among Community Health Workers in India Before and After Use of Face Shields.在印度,社区卫生工作者使用面罩前后的 SARS-CoV-2 感染情况。
JAMA. 2020 Oct 6;324(13):1348-1349. doi: 10.1001/jama.2020.15586.
3
A Single-Cell Atlas of the Human Healthy Airways.人类健康气道单细胞图谱
Indian J Ophthalmol. 2024 May 1;72(5):664-671. doi: 10.4103/IJO.IJO_1437_23. Epub 2023 Dec 26.
4
COVID-19 and Alzheimer's Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future.COVID-19 和阿尔茨海默病具有共同的神经和眼科表现:后疫情时代的双向风险。
Cells. 2023 Nov 10;12(22):2601. doi: 10.3390/cells12222601.
5
Non-Pharmacological Strategies and Interventions for Effective COVID-19 Control: A Narrative Review.有效控制新冠病毒的非药物策略与干预措施:一项叙述性综述
J Clin Med. 2023 Oct 11;12(20):6465. doi: 10.3390/jcm12206465.
6
Incidence and clinical characteristic of ocular surface manifestation: an evaluation of conjunctival swab results in Corona Virus 2019 (COVID-19) patients in Jakarta, Indonesia.眼表表现的发病率及临床特征:对印度尼西亚雅加达2019冠状病毒病(COVID-19)患者结膜拭子结果的评估
J Ophthalmic Inflamm Infect. 2023 Apr 25;13(1):20. doi: 10.1186/s12348-023-00343-4.
7
Convergent Evolution Dynamics of SARS-CoV-2 and HIV Surface Envelope Glycoproteins Driven by Host Cell Surface Receptors and Lipid Rafts: Lessons for the Future.SARS-CoV-2 和 HIV 表面包膜糖蛋白的趋同进化动力学受宿主细胞表面受体和脂筏驱动:对未来的启示。
Int J Mol Sci. 2023 Jan 18;24(3):1923. doi: 10.3390/ijms24031923.
8
Insights on the possibility of SARS-CoV-2 transmission through the eyes.关于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)通过眼睛传播可能性的见解。
Int J Ophthalmol. 2022 Nov 18;15(11):1857-1863. doi: 10.18240/ijo.2022.11.18. eCollection 2022.
9
Conjunctival Swab Findings in 484 COVID-19 Patients in Four Hospital Centers in Slovakia.斯洛伐克四个医院中心484例新冠肺炎患者的结膜拭子检查结果
Vision (Basel). 2022 Jul 22;6(3):46. doi: 10.3390/vision6030046.
10
A Systematic Literature Review and Bibliometric Analysis of Ophthalmology and COVID-19 Research.眼科与新冠肺炎研究的系统文献综述和文献计量分析
J Ophthalmol. 2022 May 24;2022:8195228. doi: 10.1155/2022/8195228. eCollection 2022.
Am J Respir Crit Care Med. 2020 Dec 15;202(12):1636-1645. doi: 10.1164/rccm.201911-2199OC.
4
Ocular Surface Expression of SARS-CoV-2 Receptors.SARS-CoV-2 受体在眼表面的表达。
Ocul Immunol Inflamm. 2020 Jul 3;28(5):735-738. doi: 10.1080/09273948.2020.1772314. Epub 2020 Jun 26.
5
ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection.ACE2 和 TMPRSS2 在上皮细胞表面表达,提示其对 SARS-CoV-2 感染的易感性。
Ocul Surf. 2020 Oct;18(4):537-544. doi: 10.1016/j.jtos.2020.06.007. Epub 2020 Jun 13.
6
and variants and expression as candidates to sex and country differences in COVID-19 severity in Italy.以及作为意大利COVID-19严重程度的性别和国家差异候选因素的变异和表达。
Aging (Albany NY). 2020 Jun 5;12(11):10087-10098. doi: 10.18632/aging.103415.
7
Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis.物理隔离、口罩和眼部防护预防 SARS-CoV-2 和 COVID-19 的人际传播:系统评价和荟萃分析。
Lancet. 2020 Jun 27;395(10242):1973-1987. doi: 10.1016/S0140-6736(20)31142-9. Epub 2020 Jun 1.
8
Retinal findings in patients with COVID-19.新型冠状病毒肺炎患者的视网膜病变
Lancet. 2020 May 23;395(10237):1610. doi: 10.1016/S0140-6736(20)31014-X. Epub 2020 May 12.
9
A Novel CD147 Inhibitor, SP-8356, Attenuates Pathological Fibrosis in Alkali-Burned Rat Cornea.一种新型 CD147 抑制剂 SP-8356 可减轻碱烧伤大鼠角膜病理性纤维化。
Int J Mol Sci. 2020 Apr 23;21(8):2990. doi: 10.3390/ijms21082990.
10
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2.使用临床级别的可溶性人血管紧张素转化酶 2 抑制工程化人类组织中的 SARS-CoV-2 感染。
Cell. 2020 May 14;181(4):905-913.e7. doi: 10.1016/j.cell.2020.04.004. Epub 2020 Apr 24.